Monitoring Brain Waves in Response to Visual and/or Auditory Stimulation in Parkinson's Disease Patients
NCT ID: NCT02768896
Last Updated: 2016-06-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2016-06-30
2018-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Self-motion Perception in Parkinson's Disease
NCT03137238
Brain Activity During Gait in Parkinson's
NCT04863560
Visuomotor Control in Parkinson Disease
NCT06918938
High Frequency Light, Sound, and Tactile Stimulation to Improve Motor and Cognitive Deficits in Parkinson's Disease
NCT05268887
Neurofeedback Training for PD
NCT05987865
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The voltage fluctuation (in hundreds of microvolts) will be recorded using the EEG cap and amplifier into a computer.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Baseline
Patients will walk naturally with EEG measuring brain waves
No interventions assigned to this group
Visual stimuli
Patients will walk naturally with EEG measuring brain waves while seeing a grid through glasses
Baseline
Patients will walk naturally with EEG measuring brain waves
visual stimuli
Patients will walk naturally with EEG measuring brain waves while seeing a grid through glasses
Auditory stimuli
Patients will walk naturally with EEG measuring brain waves while hearing an auditory stimuli
Baseline
Patients will walk naturally with EEG measuring brain waves
Auditory stimuli
Patients will walk naturally with EEG measuring brain waves while hearing an auditory stimuli
Visual and auditory stimuli
Patients will walk naturally with EEG measuring brain waves while seeing a grid through glasses and hearing an auditory stimuli simultaneously
Baseline
Patients will walk naturally with EEG measuring brain waves
Visual and auditory stimuli
Patients will walk naturally with EEG measuring brain waves while seeing a grid through glasses and hearing an auditory stimuli simultaneously
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Baseline
Patients will walk naturally with EEG measuring brain waves
visual stimuli
Patients will walk naturally with EEG measuring brain waves while seeing a grid through glasses
Auditory stimuli
Patients will walk naturally with EEG measuring brain waves while hearing an auditory stimuli
Visual and auditory stimuli
Patients will walk naturally with EEG measuring brain waves while seeing a grid through glasses and hearing an auditory stimuli simultaneously
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with dementia
* Patients that are blind
* Patients that have severe hearing impairment
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Technion, Israel Institute of Technology
OTHER
Rambam Health Care Campus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ilana Schlesinger, MD
Role: PRINCIPAL_INVESTIGATOR
Rambam Health Care Campus
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Ilana Schlesinger, MD
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0182-16RMB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.